Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Conference News TVT 2023

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

Michael O'Riordan

June 13, 2023

Presentation TVT 2023

Bioprosthetic Surgical Valves in Intermediate-risk Patients: 1-Year Outcomes of the PARTNER 3 Mitral Valve-in-Valve Study

Presenter: Mayra Guerrero

June 10, 2023

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

News Conference News TVT 2023

Latest-Generation MitraClip Devices Make Strides Against Residual MR

Shelley Wood

June 09, 2023

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

Presentation TVT 2022

ViMAC: Clinical Experience With Surgically Implanted Balloon-Expandable Valves

Presenter: Isaac George

June 10, 2022

News Conference News TVT 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

Todd Neale

July 22, 2021

Presentation TVT 2021

RV Response to TR Reduction: Surgical & Transcatheter Experience

Presenter: Philipp Lurz

July 22, 2021

News Conference News TVT 2021

Timing of Mitral Surgery After Failed TEER Influences Outcomes

Todd Neale

July 21, 2021

News Conference News TVT 2020

Newer TAVR Devices Reassure in Failed Surgical Valves

Shelley Wood

June 20, 2020

News Conference News TVT 2019

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Shelley Wood

June 19, 2019

News Conference News TVT 2019

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Michael O'Riordan

June 17, 2019

News Conference News TVT 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Michael O'Riordan

June 14, 2019

Presentation TVT 2019

Percutaneous Transeptal Mitral Valve Implantation in Failed Surgical Bioprosthetic Valves – Early Experience in Brazil

Presenter: Pedro Nicz

June 14, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

Presentation TVT 2016

TVT 1146: First-in-Man Experience of Using the Aegis Surgical Transit (TM) System for Suprasternal TAVR Using a Self-Expanding Valve

Presenter: John P Vavalle, MD, MHS, FACC

June 17, 2016

Presentation TVT 2016

Highlights From the SAPIEN 3 Experience in Intermediate-Risk Patients

Presenter: Vinod H. Thourani

June 16, 2016

Advertisement

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

Bioprosthetic Surgical Valves in Intermediate-risk Patients: 1-Year Outcomes of the PARTNER 3 Mitral Valve-in-Valve Study

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Latest-Generation MitraClip Devices Make Strides Against Residual MR

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

ViMAC: Clinical Experience With Surgically Implanted Balloon-Expandable Valves

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

RV Response to TR Reduction: Surgical & Transcatheter Experience

Timing of Mitral Surgery After Failed TEER Influences Outcomes

Newer TAVR Devices Reassure in Failed Surgical Valves

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Percutaneous Transeptal Mitral Valve Implantation in Failed Surgical Bioprosthetic Valves – Early Experience in Brazil

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

TVT 1146: First-in-Man Experience of Using the Aegis Surgical Transit (TM) System for Suprasternal TAVR Using a Self-Expanding Valve

Highlights From the SAPIEN 3 Experience in Intermediate-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content